SERPINB2 Antikörper (Middle Region)
-
- Target Alle SERPINB2 Antikörper anzeigen
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Ratte, Maus, Kaninchen, Rind (Kuh), Meerschweinchen, Pferd, Hund, Schaf
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SERPINB2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- GKIPNLLPEG SVDGDTRMVL VNAVYFKGKW KTPFEKKLNG LYPFRVNSAQ
- Homologie
- Cow: 86%, Dog: 100%, Guinea Pig: 92%, Horse: 93%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 85%, Sheep: 86%
- Produktmerkmale
- This is a rabbit polyclonal antibody against SERPINB2. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human SERPINB2
- Top Product
- Discover our top product SERPINB2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 415 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma." in: Molecular cancer therapeutics, Vol. 6, Issue 1, pp. 203-12, (2007) (PubMed).
: "
-
Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma." in: Molecular cancer therapeutics, Vol. 6, Issue 1, pp. 203-12, (2007) (PubMed).
-
- Target
- SERPINB2 (Plasminogen Activator Inhibitor 2 (SERPINB2))
- Andere Bezeichnung
- SERPINB2 (SERPINB2 Produkte)
- Synonyme
- HsT1201 antikoerper, PAI antikoerper, PAI-2 antikoerper, PAI2 antikoerper, PLANH2 antikoerper, SERPINB2 antikoerper, Planh2 antikoerper, ovalbumin antikoerper, Pai2a antikoerper, serpin family B member 2 antikoerper, serpin peptidase inhibitor, clade B (ovalbumin), member 2 antikoerper, serine (or cysteine) peptidase inhibitor, clade B, member 2 antikoerper, SERPINB2 antikoerper, Serpinb2 antikoerper
- Substanzklasse
- Amino Acid
- Hintergrund
-
SERPINB2 inhibits urokinase-type plasminogen activator. The monocyte derived PAI-2 is distinct from the endothelial cell-derived PAI-1.
Alias Symbols: HsT1201, PAI, PAI-2, PAI2, PLANH2
Protein Interaction Partner: UBC, APP, PRPF8, PSMB1, RBL2, RB1, IRF3, PLAU, SERPINB2,
Protein Size: 415 - Molekulargewicht
- 44 kDa
- Gen-ID
- 5055
- NCBI Accession
- NM_002575, NP_002566
- UniProt
- P05120
- Pathways
- Autophagie
-